The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Significance and Biological Importance of Pyrimidine in the Microbial World
Open accessAbstract
Microbes are unique creatures that adapt to varying lifestyles and environment resistance in extreme or adverse conditions. The genetic architecture of microbe may bear a significant signature not only in the sequences position, but also in the lifestyle to which it is adapted. It becomes a challenge for the society to find new chemical entities which can treat microbial infections. The present review aims to focus on account of important chemical moiety, that is, pyrimidine and its various derivatives as antimicrobial agents. In the current studies we represent more than 200 pyrimidines as antimicrobial agents with different mono-, di-, tri-, and tetrasubstituted classes along with in vitro antimicrobial activities of pyrimidines derivatives which can facilitate the development of more potent and effective antimicrobial agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive Heterocyclic Chemistry II
KATRITZKY, A. R., Rees, C. W., & Scriven, E. F. V. (1997) · Medical Entomology and Zoology · Cited by 8,499
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Mitsuya, H., Weinhold, K. J., Furman, P. A., St Clair, M. H., Lehrman, S. N., Gallo, R. C., Bolognesi, D., Barry, D. W., & Broder, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.20.7096 · Cited by 1,866
Foye's Principles of Medicinal Chemistry
Foye, W. O., Lemke, T., & Williams, D. A. (2012) · Cited by 1,407
100 years of the biginelli dihydropyrimidine synthesis
Oliver Kappe, C. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)87971-0 · Cited by 1,228
Comprehensive medicinal chemistry
Timmerman, H., Bast, A., Van der Goot, H., Vermeulen, N. P. E., & Zeelen, F. J. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90535-z · Cited by 1,163
Origins and evolution of antibiotic resistance.
DAVIES, J. E. (1996) · PubMed · Cited by 1,033
Antiviral drugs in current clinical use
De Clercq, E. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.02.009 · Cited by 947
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
Mechanisms of bacterial biocide and antibiotic resistance: ANTIBIOTIC AND BIOCIDE RESISTANCE
Poole, K. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.8.x · Cited by 513
White, N. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351107 · Cited by 491
Triclosan: a widely used biocide and its link to antibiotics
Schweizer, H. (2001) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(01)00273-7 · Cited by 447
Active efflux, a common mechanism for biocide and antibiotic resistance
Levy, S. B. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.4.x · Cited by 401
Specific Binding of 4-Amino Folic Acid Analogues by Folic Acid Reductase
Werkheiser, W. C. (1961) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64324-8 · Cited by 377
Dihydrofolate reductase inhibitors as antibacterial agents
Hawser, S., Lociuro, S., & Islam, K. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.052 · Cited by 335
Sharma, P., Rane, N., & Gurram, V. K. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.014 · Cited by 335
Novel approaches to developing new antibiotics for bacterial infections
Coates, A. R. M., & Hu, Y. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707432 · Cited by 218
Jeu, L., Piacenti, F. J., Lyakhovetskiy, A. G., & Fung, H. B. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80126-1 · Cited by 213
LEE, H., KIM, B., AHN, J., KANG, S., LEE, J., SHIN, J., AHN, S., LEE, S., & YOON, S. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2005.03.019 · Cited by 179
Hassan, M.-E.-T., van der Lelie, D., Springael, D., Römling, U., Ahmed, N., & Mergeay, M. (1999) · Gene · doi:10.1016/s0378-1119(99)00349-2 · Cited by 165
PYRIMIDINE DERIVATIVES AS ANTAGONISTS OF PTEROYLGLUTAMIC ACID
Hitchings, G. H., Elion, G. B., VanderWerff, H., & Falco, E. A. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57361-0 · Cited by 162
Antibiotic and antiseptic resistance: impact on public health
Levy, S. B. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200010001-00008 · Cited by 157
Therapeutic Drug Monitoring of Antifungals: Pharmacokinetic and Pharmacodynamic Considerations
Smith, J., & Andes, D. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318167d0e0 · Cited by 156
Overcoming antimicrobial resistance by targeting resistance mechanisms
Poole, K. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775514 · Cited by 142
van Leeuwen, R., Katlama, C., Kitchen, V. S., Boucher, C. A., Tubiana, R., McBride, M., Ingrand, D., Weber, J. N., Hill, A. M., McDade, H., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.5.1166 · Cited by 128
Balzarini, J. M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf037 · Cited by 117
Mechanisms of bacterial insusceptibility to biocides
Russell, A. D. (2001) · American Journal of Infection Control · doi:10.1067/mic.2001.115671 · Cited by 111
Falcipain Inhibitors: Optimization Studies of the 2-Pyrimidinecarbonitrile Lead Series
Coterón, J. M., Catterick, D., Castro, J., Chaparro, M. J., Díaz, B., Fernández, E., Ferrer, S. B., Gamo, F., Gordo, M., Gut, J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100556b · Cited by 108
Abu‐Hashem, A. A., Shehry, M. F. E., & Badria, F. A.-E. (2010) · Acta Pharmaceutica · doi:10.2478/v10007-010-0027-6 · Cited by 106
Anti-infective research and development—problems, challenges, and solutions
Bradley, J. S., Guidos, R., Baragona, S., Bartlett, J. G., Rubinstein, E., Zhanel, G. G., Tino, M. D., Pompliano, D. L., Tally, F., Tipirneni, P., et al. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70689-2 · Cited by 99
Tarnchompoo, B., Sirichaiwat, C., Phupong, W., Intaraudom, C., Worachart Sirawaraporn, A., Kamchonwongpaisan, S., Vanichtanankul, J., Thebtaranonth, Y., & Yuthavong, Y. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010131q · Cited by 98
A rapid HPLC assay for voriconazole in human plasma
Gage, R., & Stopher, D. A. (1998) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(98)00004-1 · Cited by 94
Koch, U., Attenni, B., Malancona, S., Colarusso, S., Conte, I., Filippo, M. D., Harper, S., Pacini, B., Giomini, C., Thomas, S., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051064t · Cited by 87
Carr, A. D., Penny, R., & Cooper, D. A. (1993) · AIDS · doi:10.1097/00002030-199301000-00010 · Cited by 85
Virsodia, V. R., Pissurlenkar, R. R. S., Manvar, D., Dholakia, C., Adlakha, P., Shah, A. K., & Coutinho, E. C. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.08.004 · Cited by 79
Wyss, P. C., Gerber, P. R., HARTMAN, P. G., Hubschwerlen, C., Locher, H. H., Marty, H.-P., & Ståhl, M. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020495y · Cited by 72
Synthesis of 2-sulfanyl-6-methyl-1,4-dihydropyrimidines as a new class of antifilarial agents
Singh, B. K., Mishra, M., Saxena, N., Yadav, G. P., Maulik, P. R., Sahoo, M. K., Gaur, R. L., Murthy, P. K., & Tripathi, R. P. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.01.038 · Cited by 69
Epidemiology of antibiotic resistance
Livermore, D. M. (2000) · Intensive Care Medicine · doi:10.1007/s001340051113 · Cited by 69
Sriram, D., Bal, T. R., & Yogeeswari, P. (2005) · PubMed · Cited by 67
Everard Napier, L. (1951) · PubMed · Cited by 56
Nawrozkij, M. B., Rotili, D., Tarantino, D., Botta, G., Еремийчук, А. С., Musmuca, I., Ragno, R., Samuele, A., Zanoli, S., Armand‐Ugón, M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800340w · Cited by 55
Govindasami, T., Pandey, A., Nithya, P., et al. (2011) · International Journal of Organic Chemistry · doi:10.4236/ijoc.2011.13012 · Cited by 52
Rodrigues, A. L. S., Rosa, J. M., Gadotti, V. M., Goulart, E. C., Santos, M. M. M., Silva, A., Sehnem, B., Rosa, L. S., Gonçalves, R. M., Corrêa, R., et al. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.08.003 · Cited by 49
New developments in anti-HIV chemotherapy
Clercq, E. D. (2001) · Il Farmaco · doi:10.1016/s0014-827x(01)01007-2 · Cited by 48
Sharma, P., Kumar, A., & Sharma, M. C. (2006) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.03.022 · Cited by 48
Manetti, F., Esté, J. A., Clotet‐Codina, I., Armand‐Ugón, M., Maga, G., Crespan, E., Cancio, R., Mugnaini, C., Bernardini, C., Togninelli, A., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050744t · Cited by 46
Johar, M., Manning, T., Tse, C., Desroches, N., Agrawal, B., Kunimoto, D. Y., & Kumar, R. K. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0703901 · Cited by 39
Srivastav, N. C., Rai, D., Tse, C., Agrawal, B., Kunimoto, D. Y., & Kumar, R. K. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100568q · Cited by 34
Chapter 6.1: Six-Membered Ring Systems: Pyridine and Benzo Derivatives
Hopper, D. W., Crombie, A. L., Clemens, J. J., & Kwon, S. (2009) · Progress in heterocyclic chemistry · doi:10.1016/s0959-6380(09)70039-x · Cited by 10
Synthesis and antibacterial activity of 4-(1-naphthyl)-6-arylpyrimidin-2-(1H)-ones
Vijayaramalingam, K., Chandrasekaran, S., & Nagarajan, S. (2007) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-007-0056-8 · Cited by 4
Metadata
- Authors
- Sharma, V., Chitranshi, N., & Agarwal, A. K.
- Venue
- International Journal of Medicinal Chemistry
- Publisher
- Wiley
- Published
- 2014-03-23
- Volume
- 2014
- Pages
- 1-31
- ISSN
- 2090-2069 (ISSN-L)
- 2090-2077
- OpenAlex
- W1998249550
- Cited by
- 279
- References
- 50
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.